Paloma Partners Management CO Pfizer Inc Put Options Transaction History

Paloma Partners Management CO

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $5.21 Million - $6.1 Million	206,200 New	206,200 $5.77 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1.4 Million - $1.63 Million	43,500 Added 20.08%	260,100 $8.63 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $3.42 Million - $3.95 Million	-94,600 Reduced 30.4%	216,600 $7.94 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $11.4 Million - $14.9 Million	290,000 Added 1367.92%	311,200 $12.7 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $4.33 Million - $5.65 Million	-103,600 Reduced 83.01%	21,200 $1.09 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $5.46 Million - $6.67 Million	124,800 New	124,800 $5.46 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $9.32 Million - $10.6 Million	-283,100 Reduced 70.99%	115,700 $4.53 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $5.37 Million - $6.96 Million	165,200 Added 70.72%	398,800 $14.3 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $124,092 - $150,516	3,600 Added 1.57%	233,600 $10.3 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $5.85 Million - $6.24 Million	177,500 Added 338.1%	230,000 $8.34 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $449,931 - $521,982	-14,100 Reduced 21.17%	52,500 $1.86 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $113,084 - $119,986	-3,400 Reduced 4.86%	66,600 $2.41 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $2.17 Million - $2.39 Million	70,000	70,000 $2.5 Million

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.